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Abstract 
Von Meyenburg complexes (VMC) are a cluster of benign liver malformations including 
biliary cystic lesions, with congenital fibrocollagenous stroma. This rare entity can 
mimick multiple secondary hepatic lesions. We report a case of a 56-year-old woman 
who had multiples liver lesions 12 years after operation for breast cancer. Biopsy of the 
hepatic lesion confirmed the diagnosis of VMC. Preoperative discovery of multiple 
gray-white nodular lesions scattered on the surface of the liver should not always 
contraindicate curative liver resection. The diagnosis of VMC should be known and 
confirmed with liver biopsy. 
 
Case Report 
A 56-year-old woman was operated in 1996 for breast cancer. Ten years later, levels of serum tumor 
marker CA15-3 progressively increased until 2N although other serum tumor markers (α-fetoprotein, 
carcinoembryonic antigen, carbohydrate antigen 19-9) were normal. Axial contrast-enhanced multislice 
CT scan showed a solitary and hypovascular 4-cm lesion located in the right lobe of the liver 
(segment VII). Liver MRI found this lesion in segment VII to be associated with multiple and small 
lesions with high signal intensity scattered throughout the liver especially in the subcapsular area in 
T2-weighted images (fig. 1a, b). After contrast injection, the multiple masses showed irregular 
progressive enhancement from arterial phase through delayed phase. Gastroscopy and coloscopy did  
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not find new tumors and PET scan showed hyperfixation only on the hepatic lesion in segment VII. The 
diagnosis of a single liver metastasis of breast cancer was suspected although its characteristics were 
unusual (hypovascular lesion). The diagnosis of von Meyenburg complexes (VMC) was also suspected 
preoperatively, but the presence of multiple secondary hepatic lesions could not be dismissed because of 
breast cancer history. Percutaneous biopsy of the largest hepatic lesion found fibrosis but no malignant 
infiltration and could neither confirm the diagnosis of metastasis of breast cancer nor the diagnosis of 
VMC. Since this tumor had unusual characteristics, we performed laparoscopic assessment to obtain 
histological proof of malignancy. During laparoscopy, multiple gray-white nodular lesions (about 0.5–
1 cm in diameter) were found on the surface of the liver (fig. 1c). A liver biopsy was performed because 
we feared multiple liver metastases (contraindication of curative resection). Histological examination 
confirmed the diagnosis of multiple benign VMC (biliary hamartomas) encompassed by major fibrous 
stroma. After conversion to laparotomy, right hepatectomy was performed and the pathological 
findings of the specimen confirmed the liver metastasis of the breast cancer in segment VII (without 
argument for cholangiocarcinoma) associated with multifocal, irregularly dilated tinged bile ducts. The 
patient was discharged from the hospital 9 days after surgery without complications. 
Discussion 
VMC is a cluster of benign liver malformations including biliary cystic lesions, with 
congenital fibrocollagenous stroma [1]. This entity corresponds to ductal plate 
malformation, which explains why they can be found in association with other congenital 
intrahepatic abnormalities, such as congenital hepatic fibrosis, Caroli’s syndrome and 
polycystic liver disease. VMC is detected incidentally in 0.6 to 5.6% of reported autopsies 
[2]. VMC may be associated with an increased incidence of cholangiocarcinoma and 
cystic disease [3]. VMC are usually asymptomatic but clinical findings including jaundice, 
cholangitis, epigastralgias and fever have been reported [1, 4]. Biliary hamartomas are 
known as either solitary or multiple millimetric lesions [3]. When these lesions are 
multiple, deep and larg (many millimeters in diameter), they can simulate secondary 
metastatic lesions particularly in case of cancer history and so contraindicate curative 
resection. Preoperative characteristics of VMC should be known. Ultrasound can show 
hypoechoic (larger cysts) and/or hyperechoic structures (smaller cysts) with ‘comet-tail’ 
echoes [5]. In some case, these hyperechoic structures correspond to small stones inside 
the dilated bile ducts. Nonenhanced CT shows hypodense, small hepatic nodules, 
scattered throughout both liver lobes, measuring less than 15 mm in diameter. The 
enhancement is variable on post-contrast CT images [6]. The best imaging to diagnose 
VMC is MRI with typically hypointense and well-defined lesions in T1-weighted images 
and hyperintense lesions in T2-weighted images [3, 6, 7]. Semelka et al. reported a thin 
rim enhancement on early postgadolinium images that persisted until late 
postgadolinium images [3]. VMC was suspected preoperatively in our patient, but 
confirmation of the diagnosis required further investigations particularly because of 
cancer history. Macroscopically, VMC are grayish white nodules measuring 1 to 15 mm 
in size that are scattered throughout the liver, particularly below the capsule of the liver, 
in the periportal region of hepatic lobules. A definitive diagnosis of VMC requires 
histopathologic examination of the specimen because its findings are nonspecific and 
easily confused with malignant liver diseases [4]. Microscopically, VMC are characterized 
by cystic dilatations of the bile duct or clusters of mature bile duct of various sizes, 
periductal glands and encompassed by fibrous stroma [8]. 
Preoperative discovery of multiple gray-white nodular lesions scattered on the surface 
of the liver should not always contraindicate curative liver resection. The diagnosis of 
VMC should be known and confirmed by liver biopsy. 
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Fig. 1. a Axial T2-weighted liver MRI showing numerous and small lesions with high signal intensity 
scattered throughout the liver especially in the subcapsular area of the right liver lobe. b Coronal MR 
cholangiopancreatography demonstrating no communication between the cystic lesions and the 
normal biliary system. c Specimen of right hepatectomy showing gray-white nodular lesions (about 
0.5 cm in diameter) scattered on the surface of the liver. d Specimen of right hepatectomy showing 
gray-white nodular lesions throughout the liver parenchyma associated to a large lesion (liver 
metastasis) with retraction of the liver capsule. e Microscopic view showing multiple bile ducts with 
slightly dilated lumens embedded in the collagenous stroma (hematoxylin and eosin, ×100). 
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